Sign Up to like & get recommendations! 0
Published in 2019 at "Rheumatology International"
DOI: 10.1007/s00296-019-04478-3
Abstract: To define the spectrum and phenotypic characteristics of systemic autoinflammatory diseases (SAIDs) other than familial Mediterranean fever (FMF) in Arab children and to delineate diagnostic evaluation. Data retrospectively collected on patients with clinical and/or genetically… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Clinical Rheumatology"
DOI: 10.1007/s10067-020-05492-8
Abstract: The clinicians initially prefer to define patients with the systemic autoinflammatory disease (SAID)’s based on recommended clinical classification criteria; then, they confirm the diagnosis with genetic testing. We aimed to compare the initial phenotypic diagnoses… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Nature Immunology"
DOI: 10.1038/ni.3777
Abstract: Autoinflammatory diseases were first recognized nearly 20 years ago as distinct clinical and immunological entities caused by dysregulation in the innate immune system. Since then, advances in genomic techniques have led to the identification of… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "International immunology"
DOI: 10.1093/intimm/dxz024
Abstract: Autoinflammatory syndromes are a group of disorders characterised by recurring episodes of inflammation as a result of specific defects in the innate immune system. Patients with autoinflammatory disease present with recurrent outbreaks of chronic systemic… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Rheumatology"
DOI: 10.1093/rheumatology/keac712
Abstract: Autoinflammatory diseases (AIDs) are defined as disorders of innate immunity. They were initially defined in contrast to autoimmune diseases because of the lack of involvement of the adaptive immune system and circulating autoantibodies. The four… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Current Opinion in Rheumatology"
DOI: 10.1097/bor.0000000000000347
Abstract: Purpose of review This article addresses the prevalence and relationship between autoinflammatory diseases and vasculitis. Recent findings Autoimmune diseases (AIDs) are a group of syndromes characterized by episodes of unprovoked inflammation due to dysregulation of… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Clinical and Experimental Dermatology"
DOI: 10.1111/ced.14508
Abstract: Recurrent fever is defined by two episodes of fever separated by a free interval of at least two weeks.1 Diseases causing recurrent fever may be classified into three categories: infections, neoplasia, and non-infectious inflammations. Recurrent… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "International Journal of Dermatology"
DOI: 10.1111/ijd.16352
Abstract: The presence of mucocutaneous manifestations has clinical significance, as it may be a part of the initial presentation or activation stage of both autoimmune and autoinflammatory rheumatic diseases. The cutaneous signs may display a particular… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Pediatric Dermatology"
DOI: 10.1111/pde.14155
Abstract: Generalized pustular psoriasis (GPP) is a severe form of psoriasis, which is rare in pediatric and adult patients. It is characterized by sterile pustular lesions that appear on erythematous skin, associated with systemic features. A… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2017-212515
Abstract: Autoinflammatory diseases (AIDs) are a relatively new family of disorders, defined about 19 years ago. Some of them are hereditary and some are not. The names given to these diseases do not follow any systematic… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "BMJ Open"
DOI: 10.1136/bmjopen-2017-021037
Abstract: Introduction Autoimmune and autoinflammatory diseases (AIDs) represent a socioeconomic burden as the second cause of chronic illness in Western countries. In this context, the TRANSIMMUNOM clinical protocol is designed to revisit the nosology of AIDs… read more here.